Aktie PHAR EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Egyptian International Pharmaceutical Industries Company

Aktien

PHAR

EGS38081C013

PHAR

Schlusskurs Egyptian Exchange
Andere Börsenplätze
 00:00:00 24.04.2024 		% 5 Tage % 1. Jan.
41,81 EGP -3,17 % Intraday Chart für Egyptian International Pharmaceutical Industries Company -7,05 % +14,55 %
01.03. Egyptian International Pharmaceutical Industries Company berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Egyptian International Pharmaceutical Industries Company meldet Gewinnergebnisse für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2023
Egyptian International Pharmaceutical Industries Company(CASE:PHAR) added to EGX 30 Index
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Nine Months Ended September 30, 2023
Medical Union Pharmaceuticals Company announced that it expects to receive funding from Egyptian International Pharmaceutical Industries Company and other investors
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2023
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2022
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Half Year Ended June 30, 2022
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2022
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2021
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Nine Months Ended September 30, 2021
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Half Year Ended June 30, 2021
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2021
Egyptian International Pharmaceutical Industries Approves Cash Dividend for 2020
Egyptian International Pharmaceutical Industries Company Appoints Ahmed Saeed Mohamed Kilany as the Company's Chairman and Managing Director
Egyptian International Pharmaceutical Industries Company's Equity Buyback announced on March 29, 2020, has expired.
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2020
Medical Union Pharmaceuticals Company announced that it expects to receive EGP 74.82 million in funding from Egyptian International Pharmaceutical Industries Company
Egyptian International Pharmaceutical Industries Company Declares Cash Dividends; Reports Earnings Results for the Year 2019
Egyptian International Pharmaceutical Industries Company announces an Equity Buyback for 1.61% of its issued share capital.
Egyptian International Pharmaceutical Industries Company authorizes a Buyback Plan.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. PHAR Aktie
  4. Nachrichten Egyptian International Pharmaceutical Industries Company
  5. Andere Sprachen